SCHEMBL5003266

SCHEMBL5003266

CC(C(=O)c1ccc(-c2ccc(NC=O)c(F)c2)cc1)C(C)(C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 2/20 0.38
CYP17A1 P05093 1/20 0.38
KIF11 P52732 3/20 0.36
ABCB1 P08183 4/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ABCC1 P33527 2/20 0.35
CHRNA1 P02708 1/20 0.35
CHRNG P07510 1/20 0.35
CHRNB1 P11230 1/20 0.35
CHRNB2 P17787 1/20 0.35
SLC6A2 P23975 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CHRND Q07001 1/20 0.35
ERN1 O75460 3/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5003268 0.87 KDM5A (0.39) KDM5AKIF11KDM4ELMNACHRNA1
SCHEMBL5005972 0.81 TAAR1 (0.37) KDM4ELMNA
SCHEMBL5005996 0.79 HDAC1 (0.40) KIF11KDM4ELMNAHSD17B10CHRNA1
SCHEMBL12430133 0.76 CYP17A1 (0.36) KDM5ACYP17A1KIF11ABCB1KDM4E
SCHEMBL1748028 0.73 CYP17A1 (0.39) KDM5ACYP17A1KIF11ABCB1ABCC1
SCHEMBL5006817 0.70 LMNA (0.40) KDM4ELMNAHSD17B10SLC6A3
SCHEMBL16539493 0.70 KDM5A (0.67) KDM5AKDM4ELMNAHSD17B10ERN1
SCHEMBL5006804 0.69 ALDH1A1 (0.47) KDM4ELMNACHRNA1CHRNGCHRNB1
SCHEMBL5438347 0.69 KIF11 (0.60) KIF11
SCHEMBL5009253 0.68 CES2 (0.43) LMNASLC6A2SLC6A3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423156-B2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2008-09-09 US disclosed